PubMed Health⌕ Search

PubMed · 12454639

Sharper tools and simpler methods.

Abstract

In this issue of The Chipping Forecast, we are witnesses to the adolescence of a class of technologies that are enabling us to monitor globally aspects of gene expression. Chip-based technologies are specific examples of a more general trend toward the implementation of systematic and comprehensive methods in biological research. We need to recognize, however, that these technologies, while seductive, can sometimes be corruptive. In other words, we must guard against committing the mortal sin of genomics by confusing throughput with output, which too often blurs the distinction between data and knowledge. Instead, we must maintain the necessary focus to achieve an ever-more operational understanding of all the molecular components and the interactions that define a cell or an organism.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Geoffrey M Duyk. 2002. Sharper tools and simpler methods.. https://doi.org/10.1038/ng1027

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules.

We previously reported that prostate derived Ets transcription factor (PDEF) is a breast tumor-associated molecule. To obtain further insights into PDEF expression in other human tumor types, a cDNA library database from human adult normal and tumor tissues was compiled and searched for PDEF distribution. The results showed that PDEF is present at relative higher frequencies in the cDNA libraries from brain, breast, lung and ovarian tumors in comparison to those from the corresponding normal tissues. RT/PCR analysis of PDEF expression in ovarian tumors confirmed that PDEF is expressed in 36 out of 51 (71%) ovarian tumors. Further comparison of the distribution of PDEF with other widely recognized cancer-associated molecules showed that PDEF has more restricted distributions than Her-2/neu, Bcl-2, survivin or telomerase in cDNA libraries from normal human tissues and more increased distribution than Her-2/neu, CA-125, Bcl-2, survivin and telomerase in cDNA libraries from brain (except survivin), breast, lung and ovarian tumors. These data together show a better tumor-association for PDEF and suggest that PDEF is a more suitable target for developing specific cancer therapies.

DNA, Complementary↗